Overview
IBIDS syndrome, also known as Tay syndrome or trichothiodystrophy with ichthyosis, is a rare autosomal recessive disorder belonging to the trichothiodystrophy (TTD) spectrum. The acronym IBIDS stands for Ichthyosis, Brittle hair, Impaired intelligence, Decreased fertility, and Short stature, which represent the cardinal features of the condition. It is caused by mutations in genes involved in nucleotide excision repair and transcription, most commonly the ERCC2 (XPD) gene, and less frequently ERCC3 (XPB) or GTF2H5 (TTDA). These genes encode components of the TFIIH transcription/repair complex, and their dysfunction leads to defective DNA repair and transcriptional abnormalities. The condition affects multiple body systems. The hair is characteristically brittle, sparse, and sulfur-deficient, showing a distinctive 'tiger tail' pattern under polarized light microscopy due to alternating light and dark bands. The skin manifests congenital ichthyosis (fish-scale-like dry skin), and patients may also have nail dystrophy. Neurological involvement includes intellectual disability of variable severity, and affected individuals typically exhibit short stature and decreased fertility. Unlike the related PIBIDS variant, classic IBIDS syndrome does not include photosensitivity, though some overlap exists within the TTD spectrum. There is currently no cure for IBIDS syndrome. Management is supportive and multidisciplinary, focusing on symptomatic treatment of ichthyosis with emollients and keratolytic agents, developmental support and special education for intellectual disability, and monitoring of growth. Genetic counseling is recommended for affected families. Prognosis varies depending on the severity of neurological and systemic involvement, and some patients may have a reduced lifespan due to recurrent infections or other complications.
Autosomal recessive
Passed on when both parents carry the same gene change; often skips generations
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for IBIDS syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for IBIDS syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Rare Disease Specialist
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to IBIDS syndrome.
Community
No community posts yet. Be the first to share your experience with IBIDS syndrome.
Start the conversation →Latest news about IBIDS syndrome
Disease timeline:
New trial: Reversing External-beam Radiotherapy-associated Fibrosis Syndrome: an Interventional Bayesian Adapti
Phase PHASE2 trial recruiting. Pravastatin (drug)
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about IBIDS syndrome
What is IBIDS syndrome?
IBIDS syndrome, also known as Tay syndrome or trichothiodystrophy with ichthyosis, is a rare autosomal recessive disorder belonging to the trichothiodystrophy (TTD) spectrum. The acronym IBIDS stands for Ichthyosis, Brittle hair, Impaired intelligence, Decreased fertility, and Short stature, which represent the cardinal features of the condition. It is caused by mutations in genes involved in nucleotide excision repair and transcription, most commonly the ERCC2 (XPD) gene, and less frequently ERCC3 (XPB) or GTF2H5 (TTDA). These genes encode components of the TFIIH transcription/repair complex,
How is IBIDS syndrome inherited?
IBIDS syndrome follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does IBIDS syndrome typically begin?
Typical onset of IBIDS syndrome is neonatal. Age of onset can vary across affected individuals.
Which specialists treat IBIDS syndrome?
1 specialists and care centers treating IBIDS syndrome are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.